Treatment administration
| Treatment administration . | . |
|---|---|
| Median no. of cycles administered (range) | 7 (1-40) |
| Total number of cycles administered | 400 |
| Lenalidomide | |
| Number of cycles administered | 400 |
| Median % of targeted dose (range) | 67 (3.2-100) |
| No. of patients with dose reduction (%) | 20 (57) |
| Total reductions | 25 |
| Reasons for reductions | |
| Hematologic adverse event | 6 |
| Dermatology/skin/rash | 9 |
| Infection | 2 |
| Other | 8 |
| Cyclophosphamide | |
| No. of cycles administered | 268 |
| Median % of targeted dose (%) | 97 (0-108.3) |
| No. of patients with dose reduction (%) | 20 (57) |
| Total reductions | 28 |
| Reasons for reductions | |
| Hematologic adverse event | 16 |
| Renal | 1 |
| Infection | 3 |
| Other | 8 |
| Dexamethasone | |
| No. of cycles administered | 384 |
| Median % of targeted dose (range) | 75 (0-100) |
| No. of patients with dose reduction (%) | 21 (60) |
| Total reductions | 44 |
| Reasons for reductions | |
| Gastrointestinal | 3 |
| Edema | 7 |
| Weakness | 3 |
| Confusion/mood alteration | 7 |
| Other | 24 |
| Treatment administration . | . |
|---|---|
| Median no. of cycles administered (range) | 7 (1-40) |
| Total number of cycles administered | 400 |
| Lenalidomide | |
| Number of cycles administered | 400 |
| Median % of targeted dose (range) | 67 (3.2-100) |
| No. of patients with dose reduction (%) | 20 (57) |
| Total reductions | 25 |
| Reasons for reductions | |
| Hematologic adverse event | 6 |
| Dermatology/skin/rash | 9 |
| Infection | 2 |
| Other | 8 |
| Cyclophosphamide | |
| No. of cycles administered | 268 |
| Median % of targeted dose (%) | 97 (0-108.3) |
| No. of patients with dose reduction (%) | 20 (57) |
| Total reductions | 28 |
| Reasons for reductions | |
| Hematologic adverse event | 16 |
| Renal | 1 |
| Infection | 3 |
| Other | 8 |
| Dexamethasone | |
| No. of cycles administered | 384 |
| Median % of targeted dose (range) | 75 (0-100) |
| No. of patients with dose reduction (%) | 21 (60) |
| Total reductions | 44 |
| Reasons for reductions | |
| Gastrointestinal | 3 |
| Edema | 7 |
| Weakness | 3 |
| Confusion/mood alteration | 7 |
| Other | 24 |